Inhibitory effects of lysophosphatidic acid receptor-5 on cellular functions of sarcoma cells

References

• Chen P, Parks WC. 2009. Role of matrix metalloproteinases in epithelial migration. J Cell Biochem 108:1233–1243
   PubMed Web of Science ®Google Scholar
• Contos JJA, Ishii I, Chun J. 2000. Lysophosphatidic acid receptors. Mol Pharmacol 58:1188–1196
   PubMed Web of Science ®Google Scholar
• Dahlin DC, Unni KK. 1968. Osteosarcoma. In: Dahlin DC, Unni KK, Editors. Bone tumors. General aspects and data on 8542 cases, 4th ed. Illinois: Charles C. Thomas Publisher. p 269–307
   Google Scholar
• Ferrara N, Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med 9:669–676
   PubMed Web of Science ®Google Scholar
• Folkman J. 1971. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182–1186
   PubMed Web of Science ®Google Scholar
• Fukushima N. 2004. LPA in neural cell development. J Biol Chem 277:45428–45434
   Google Scholar
• Furuta D, Yamane M, Tsujiuchi T, Moriyama R, Fukushima N. 2012. Lysophosphatidic acid induces neurite branch formation through LPA3. Mol Cell Neurosci 50:21–34
   Google Scholar
• Goetzl EJ, Dolezalova H, Kong Y, Hu Y-L, Jaffe RB, Kalli KR, Conover CA. 1999. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. Cancer Res 59:5370–5375
   PubMed Web of Science ®Google Scholar
• Hayashi M, Okabe K, Yamawaki Y, Teranishi M, Honoki K, Mori T, Fukushima N, Tsujiuchi T. 2011. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun 405:450–454
   PubMedGoogle Scholar
• Hayashi M, Okabe K, Kato K, Okumura M, Fukui R, Fukushima N, Tsujiuchi T. 2012. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett 316:91–96
   PubMed Web of Science ®Google Scholar
• Hu Y-L, Tee M-K, Goetzl EJ, Auersperg N, Mills GB, Ferrara N, Jaffe RB. 2001. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst 93:762–768
   PubMed Web of Science ®Google Scholar
• Honoki K, Mori T, Tsutsumi M, Tsujiuchi T, Kido A, Morishita T, Miyauchi Y, et al. 1998. Heterogenous pattern of gene expression in cloned cell lines established from a rat transplantable osteosarcoma lung metastatic nodule. Cancer Lett 125:221–228
   Google Scholar
• Ishii I, Contos JJA, Fukushima N, Chun J. 2000. Functional comparisons of the lysophosphatidic acid receptors, LPA1/VZG-1/EDG-2, LPA2/EDG-4, and LPA3/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol Pharmacol 58:895–902
   PubMedGoogle Scholar
• Ishii I, Fukushima N, Ye X, Chun J. 2004. Lysophospholipid receptors: Signaling and biology. Annu Rev Biochem 73:321–354
   PubMed Web of Science ®Google Scholar
• Kato K, Yoshikawa K, Tanabe E, Kitayoshi M, Fukui R, Fukushima N, Tsujiuchi T. 2012a. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells. Tumor Biol 33:1739–1744
   Google Scholar
• Kato K, Fukui R, Okabe K, Tanabe E, Kitayoshi M, Fukushima N, Tsujiuchi T. 2012b. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem Biophys Res Commun 417:790–793
   PubMedGoogle Scholar
• Kessenbrock K, Plaks V, Werb Z. 2010. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141:52–67
   PubMed Web of Science ®Google Scholar
• Kitayoshi M, Kato K, Tanabe E, Yoshikawa K, Fukui R, Fukushima N, Tsujiuchi T. 2012. Enhancement of endothelial cell migration by constitutively active LPA1-expressing tumor cells. Biochem Biophys Res Commun 422:339–343
   Google Scholar
• Lee CW, Rivera GS, Dubin AE, Chun J. 2006. GPR92 as a new G12/13 and Gq coupled lysophosphatidic acid receptor that increases cAMP: LPA5. J Biol Chem 281:23589–23597
   PubMed Web of Science ®Google Scholar
• Lin M-E, Herr DR, Chun J. 2010. Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 91:130–138
   PubMed Web of Science ®Google Scholar
• Lin M-E, Rivera RR, Chun J. 2012. Target deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J Biol Chem 287:17608–17617
   PubMed Web of Science ®Google Scholar
• Noguchi K, Herr D, Mutoh T, Chun J. 2009. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9:15–23
   PubMed Web of Science ®Google Scholar
• Okabe K, Hayashi M, Kato K, Okumura M, Fukui R, Honoki K, Fukushima N, Tsujiuchi T. 2013. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog 52:247–254
   Google Scholar
• Okabe K, Hayashi M, Yamawaki Y, Teranishi M, Honoki K, Mori T, Fukushima N, Tsujiuchi T. 2011a. Possible involvement of lysophosphatidic acid receptor-5 gene in the acquisition of growth advantage of rat tumor cells. Mol Carcinog 50:635–642
   Google Scholar
• Okabe K, Kato K, Teranishi M, Okumura M, Fukui R, Mori T, Fukushima N, Tsujiuchi T. 2011b. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett 309:236–242
   PubMed Web of Science ®Google Scholar
• Park SY, Jeong KJ, Panupinthu N, Yu S, Lee J, Han JW, Kim JM, et al. 2011. Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression. Oncogene 30:1351–1359
   PubMed Web of Science ®Google Scholar
• Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. 2008. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta 1783:748–759
   PubMed Web of Science ®Google Scholar
• Tanabe E, Kitayoshi M, Yoshikawa K, Shibata A, Honoki K, Fukushima N, Tsujiuchi T. 2012. Loss of lysophosphatidic acid receptor-3 suppresses cell migration activity of human sarcoma cells. J Recept Signal Transduct Res 32:328–334
   PubMed Web of Science ®Google Scholar
• Tsujiuchi T, Araki M, Hirane M, Dong Y, Fukushima N. 2014. Lysophosphatidic acid receptors in cancer pathobiology. Histol Histopathol 29:313–321
   PubMed Web of Science ®Google Scholar
• Weiss SW, Enzinger FM. 1978. Malignaft fibrous histiocytoma: An analysis of 200 cases. Cancer 41:2250–2266
   PubMed Web of Science ®Google Scholar
• Yu S, Murph MMM, Lu Y, Liu S, Hall HS, Liu J, Stephens C, et al. 2008. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Cancer Inst 100:1630–1642
   PubMed Web of Science ®Google Scholar